Clinical Experience of Targeting Alpha Synuclein in Enteric Nerves Produced in Response to Infection Over the Life Course to Treat Parkinson’s Disease

Time: 12:00 pm
day: Day Two


• Exploring the underlying pathogenic pathways linking alpha synuclein and the enteric nervous system resulting from the aggregate impact of infection over the life course
• Demonstrating clinical activity of ENT-01 in the treatment of Parkinson’s Disease
• Ensuring clinical success – key takeaways for getting products into the clinic